Drugs / pethidin hydrochlorid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01567657 Comparator | Jan 2012 → Jan 2013 | hypotensive disorder | Kantonsspital Münsterlingen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pethidin hydrochlorid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01567657 ↗ |
| Known as | Pethidin hydrochlorid = Meperidine (USA) | “Pethidin hydrochlorid = Meperidine (USA)” NCT01567657 ↗ |
| Route | Intravenous | “Pethidin hydrochlorid: 25 mg iv. at the beginning of the examination” NCT01567657 ↗ |